Search Results - "Khalil, E A G"

Refine Results
  1. 1

    Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis by Noazin, Sassan, Khamesipour, Ali, Moulton, Lawrence H, Tanner, Marcel, Nasseri, Kiumarss, Modabber, Farrokh, Sharifi, Iraj, Khalil, E.A.G, Bernal, Ivan Dario Velez, Antunes, Carlos M.F, Smith, Peter G

    Published in Vaccine (30-07-2009)
    “…Abstract Despite decades of investigation in countries on three continents, an efficacious vaccine against Leishmania infections has not been developed…”
    Get full text
    Journal Article
  2. 2

    Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration by Musa, Ahmed Mudawi, Noazin, Sassan, Khalil, E.A.G., Modabber, Farrokh

    “…Instead of relying on drugs to reduce the parasite burden of leishmaniasis, and waiting for the effector immune response to develop in time to control the…”
    Get full text
    Journal Article
  3. 3

    Blindness following visceral leishmaniasis: a neglected post-kala-azar complication by Khalil, E A G, Musa, A M, Younis, B M, Elfaki, M E E, Zijlstra, E E, Elhassan, A M

    Published in Tropical doctor (01-07-2011)
    “…Visceral leishmaniasis (VL) is an important cause of morbidity and mortality that affects multiple organs. Post-kala-azar ocular involvement is a serious…”
    Get more information
    Journal Article
  4. 4

    IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan by Salih, M A, Ibrahim, M E, Blackwell, J M, Miller, E N, Khalil, E A G, ElHassan, A M, Musa, A M, Mohamed, H S

    Published in Genes and immunity (01-01-2007)
    “…Post-kala-azar dermal leishmanaisis (PKDL) in Sudan is associated with elevated interferon-gamma (IFN-gamma). To study interferon-gamma pathways in PKDL, we…”
    Get full text
    Journal Article
  5. 5

    Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan by Musa, Ahmed Mudawi, Khalil, Eltahir Awad Gasim, Younis, B. M., Elfaki, Mona Elfaki Eltahir, Elamin, M. Y., Adam, A. O. A., Mohamed, H. A. A., Dafalla, M. M. M., Abuzaid, A. A., El Hassan, Ahmed Mohamed

    Published in Journal of Tropical Medicine (01-01-2013)
    “…Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that affects more than 50% of successfully treated visceral leishmaniasis (VL) patients in Sudan…”
    Get full text
    Journal Article
  6. 6

    Leishmania donovani: Genetic diversity of isolates from Sudan characterized by PCR-based RAPD by Hamad, S.H., Khalil, E.A.G., Musa, A.M., Ibrahim, M.E., Younis, B.M., Elfaki, M.E.E., El-Hassan, A.M.

    Published in Experimental parasitology (01-08-2010)
    “…Drug unresponsiveness in patients with visceral leishmaniasis (VL) is a problem in many endemic areas . This study aimed to determine genetic diversity of…”
    Get full text
    Journal Article
  7. 7

    Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan by Khalil, E. A. G., Zijlstra, E. E., Kager, P. A., El Hassan, A. M.

    Published in Tropical medicine & international health (01-01-2002)
    “…We conducted a longitudinal study in an endemic area for visceral leishmaniasis (VL) in eastern Sudan to compare the epidemiology and clinical spectrum of…”
    Get full text
    Journal Article
  8. 8

    Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study by Aljafari, A. S., Khalil, E. A. G., Elsiddig, K. E., El Hag, I. A., Ibrahim, M. E., Elsafi, M. E. M. O., Hussein, A. M., Elkhidir, I. M., Sulaiman, G. S., Elhassan, A. M.

    Published in Cytopathology (Oxford) (01-02-2004)
    “…Despite its usefulness in the diagnosis of tuberculous lymphadenitis, fine needle aspiration cytology (FNAC) faces several limitations, and its sensitivity and…”
    Get full text
    Journal Article
  9. 9

    The development of post‐kala‐azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC) by Gasim, S., Elhassan, A. M., Kharazmi, A., Khalil, E. A. G., Ismail, A., Theander, T. G.

    Published in Clinical and experimental immunology (01-03-2000)
    “…PKDL develops in about 50% of Sudanese patients treated for visceral leishmaniasis (kala‐azar). Patients with kala‐azar were entered into this study and…”
    Get full text
    Journal Article
  10. 10

    Subtotal laparoscopic cholecystectomy influences the rate of conversion in patients with difficult laparoscopic cholecystectomy: Case series by Abdelrahim, W.E, Elsiddig, Kamal E, Wahab, A.A, Saad, M, Saeed, H, Khalil, E.A.G

    Published in Annals of medicine and surgery (01-07-2017)
    “…Abstract Objectives This study aimed to show that subtotal laparoscopic cholecystectomy (SLC) is a safe procedure that reduces the rate of conversion in…”
    Get full text
    Journal Article
  11. 11

    Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan by Khalil, EAG, Hassan, AMEl, Zijlstra, EE, Mukhtar, MM, Ghalib, HW, Musa, Breyma, Ibrahim, ME, Kamil, Areeg A, Elsheikh, M, Babiker, A, Modabber, F

    Published in The Lancet (British edition) (04-11-2000)
    “…Visceral leishmaniasis is a major cause of morbidity and mortality in the Sudan. Drug treatment is expensive, and drug resistance is becoming increasingly…”
    Get full text
    Journal Article
  12. 12

    Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan by Zijlstra, E. E., Nur, Y., Desjeux, P., Khalil, E. A. G., El‐Hassan, A. M., Groen, J.

    Published in Tropical medicine & international health (01-02-2001)
    “…We compared a strip test employing recombinant K39 (rK39) antigen and protein A/colloidal gold as read‐out agents with the rK39 ELISA for IgM and IgG…”
    Get full text
    Journal Article
  13. 13

    Socio-cultural aspects of leprosy among the Masalit and Hawsa tribes in the Sudan by EL HASSAN, L. A, KHALIL, E. A. G, EL-HASSAN, A. M

    Published in Leprosy review (01-03-2002)
    “…Social and cultural factors influencing knowledge, attitudes and practices (KAP) towards leprosy in two communities in eastern Sudan were studied to determine…”
    Get full text
    Journal Article
  14. 14

    Dichotomy of protective cellular immune responses to human visceral leishmaniasis by Khalil, E. A. G., Ayed, N. B., Musa, A. M., Ibrahim, M. E., Mukhtar, M. M., Zijlstra, E. E., Elhassan, I. M., Smith, P. G., Kieny, P. M., Ghalib, H. W., Zicker, F., Modabber, F., Elhassan, A. M.

    Published in Clinical and experimental immunology (01-05-2005)
    “…Summary Healing/protective responses in human visceral leishmaniasis (VL) are associated  with  stimulation/production  of  Th1  cytokines,  such  as …”
    Get full text
    Journal Article
  15. 15

    Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1 by MOHAMED, H. S, IBRAHIM, M. E, MILLER, E. N, PEACOCK, C. S, KHALIL, E. A. G, CORDELL, H. J, HOWSON, J. M. M, EL HASSAN, A. M, BEREIR, R. E. H, BLACKWELL, J. M

    Published in Genes and immunity (01-07-2003)
    “…Longitudinal studies in Sudan show ethnic differences in incidence and clinical phenotypes associated with Leishmania donovani. Immunologically, bias in type 1…”
    Get full text
    Journal Article
  16. 16

    Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis by Zijlstra, E.E., Khalil, E.A.G., Kager, P.A., El-Hassan, A.M.

    Published in British journal of dermatology (1951) (01-07-2000)
    “…Post‐kala‐azar dermal leishmaniasis (PKDL) is a common complication following kala‐azar (visceral leishmaniasis). In a prospective study in a village in the…”
    Get full text
    Journal Article
  17. 17

    High levels of plasma IL‐10 and expression of IL‐10 by keratinocytes during visceral leishmaniasis predict subsequent development of post‐kala‐azar dermal leishmaniasis by GASIM, S, ELHASSAN, A. M, KHALIL, E. A. G, ISMAIL, A, KADARU, A. M. Y, KHARAZMI, A, THEANDER, T. G

    Published in Clinical and experimental immunology (01-01-1998)
    “…Some patients develop post‐kala‐azar dermal leishmaniasis (PKDL) after they have been treated for the systemic infection kala‐azar (visceral leishmaniasis). It…”
    Get full text
    Journal Article
  18. 18

    rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection by Zijlstra, E E, Daifalla, N S, Kager, P A, Khalil, E A, El-Hassan, A M, Reed, S G, Ghalib, H W

    “…The rK39 enzyme-linked immunosorbent assay (ELISA) was compared with the direct agglutination test (DAT) for Leishmania donovani infection in the Sudan. rK39…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Surrogate markers of subtle renal injury in patients with visceral leishmaniasis by Khalil, E. A. G., al-Hasan, Ahmad Muhammad, al-Faki, M. E. E., Yunus, B. M., Musa, Ahmad Madwi, al-Nujumi, N. A. A.

    “…Sudanese Visceral Leishmaniasis (VL) is a disease of children that is characterized by fever, hepatosplenomegaly, lymphadenopathy, pancytopenia, and renal…”
    Get full text
    Journal Article